Research output per year
Research output per year
Personal profile
Research interests
Our group studies gut determinants of metabolic disease. Specifically, we focus on hepatic and intestinal sugar transporters in the glucose transporter (GLUT) family and the role they play in predisposing to or protecting from metabolic syndrome, type 2 diabetes mellitus and non-alcoholic fatty liver disease.
Available to Mentor:
- Undergraduate Students
- Post-Baccalaureate Students
- PhD/MSTP Students
- Health Professions Students
- Postdocs
- Residents and Fellows
Fingerprint
Dive into the research topics where Brian DeBosch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A protocol to induce systemic autophagy and increase energy metabolism in mice using PEGylated arginine deiminase
Zhang, Y. & DeBosch, B. J., Sep 16 2022, In: STAR Protocols. 3, 3, 101489.Research output: Contribution to journal › Article › peer-review
Open Access -
Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism
Zhang, Y., Higgins, C. B., Van Tine, B. A., Bomalaski, J. S. & DeBosch, B. J., Jan 18 2022, In: Cell Reports Medicine. 3, 1, 100498.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
SIRT1 selectively exerts the metabolic protective effects of hepatocyte nicotinamide phosphoribosyltransferase
Higgins, C. B., Mayer, A. L., Zhang, Y., Franczyk, M., Ballentine, S., Yoshino, J. & DeBosch, B. J., Dec 2022, In: Nature communications. 13, 1, 1074.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Splitting Hairs: Folliculin Parts the Good From the Bad in mTORC1 Control Over Lipid Metabolism
DeBosch, B., Aug 2022, In: Gastroenterology. 163, 2, p. 529 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Targeting De Novo Lipogenesis by Different Approaches Shows Promise in Nonalcoholic Steatohepatitis
DeBosch, B., Nov 2022, In: Gastroenterology. 163, 5, p. 1472 1 p.Research output: Contribution to journal › Comment/debate